We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel.
- Authors
Na'amnih, Wasef; Adler, Amos; Miller-Roll, Tamar; Cohen, Dani; Carmeli, Yehuda
- Abstract
To estimate the rate and identified risk factors for recurrent Clostridium difficile infection (rCDI) in Israel. We conducted a retro-prospective case-control study of all adult (age ≥ 18 years) patients with an initial episode of CDI (iCDI) at Tel Aviv Sourasky Medical Center from January 1, 2012 to December 31, 2014. We collected demographic, clinical, and epidemiological information for patients who were classified as recurrent (cases) and non-recurrent (control) groups. In total, 648 patients with iCDI were identified in the study. During the 36-month study period, 82 (12.7%) patients had at least one rCDI identified. We identified several factors as independent variables significantly associated with recurrent CDI: functional disability, severity of the initial infection, continuous non-Clostridium difficile antibiotic treatment with third-generation cephalosporins or clindamycin, and iCDI treatment with metronidazole and vancomycin; however, neutropenia had high measure of effect as a predictor for rCDI (adjusted odds ratio, 7.9; 95% confidence interval, 1.27-49.58; p = 0.026). The identification of the main modifiable risk factors for recurrent CDI, continuous non-Clostridium difficile antibiotics after diagnosis of the initial infection, and antibiotic treatment with third-generation cephalosporins or clindamycin are critical in reducing the spread of recurrent infection with Clostridium difficile in hospital.
- Subjects
ISRAEL; CLOSTRIDIOIDES difficile; TERTIARY care; ANTIBIOTICS; MEDICAL care; DISEASE relapse; DISEASE risk factors
- Publication
European Journal of Clinical Microbiology & Infectious Diseases, 2018, Vol 37, Issue 7, p1281
- ISSN
0934-9723
- Publication type
Article
- DOI
10.1007/s10096-018-3247-1